First signs of clinical benefit in adjuvant head and neck cancer reported at AACR 2024, paved the way for the start of Phase II part of randomized Phase I/II clinical trial in Q2 2024 – Median ...

AZN's Daiichi Sankyo-partnered datopotamab deruxtecan fails to show overall survival benefits in a breast cancer study. Stock ...

Iterum Therapeutics faces a mixed reception for its therapy for uncomplicated urinary tract infections (UTIs) as experts ...

Based on the latest analysis from Future Market Insights, the global pharmaceutical lactose market is anticipated to reach ...

In a news packed morning, Japanese drugmaker Astellas Pharma (TYO: 4503) today revealed two regulatory approvals.

Stay updated on European market trends with the latest stock index movements and bond yields.

PRNewswire/ -- "According to the latest BCC Research study, the demand for "Cell Therapy Biomanufacturing: Global Markets" is ...

The Global Recombinant Proteins Market is valued at approximately USD 2.20 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.00% over the forecast period 2024-2032.

Report Ocean has released a market research report on the In Vivo Toxicology industry, covering 150+ countries and analyzing over 1,00000 published and forthcoming reports per year. The report, ...

Allied Market Research published a report, titled, " Custom Antibody Services Market by Service (Antibody Development, Antibody Production and Purification and Antibody Fragmentation and Labeling), by ...

The udder health market is on a growth trajectory. The market is poised to reach USD 1,884.76 million by 2032, exhibiting a CAGR of 6.0% from 2024 to 2032. It was valued at USD 1,120.34 million in ...

We assessed the long-term effects and cost-effectiveness of statin therapy for older people in the contemporary UK population ...